| Management of BCG-refractory superficial bladder cancer | Bülent SOYUPAK | 465–468 |
| Non-transitional cell carcinoma of the bladder | BÜLENT GÜNLÜSOY,Murat ARSLAN,Tansu DEĞİRMENCİ,Nihat NERGİZ,Süleyman MİNARECİ,A. Rıza AYDER | 469–473 |
| Effect of transurethral resection of prostate (TURP) on progression time in patients with advanced prostate cancer receiving maximum androgen | Murat KOŞAN,Sertaç YAZICI,Öztuğ ADSAN,ONUR KAYGISIZ,Gürdal İNAL,Mesut ÇETİNKAYA | 474–478 |
| The significance of serum ferritin level in renal cell carcinoma abstract | Fikret ERDEMİR,Bekir Süha PARLAKTAŞ,Nihat ULUOCAK,Faruk ÖZCAN,Murat ÇELİK,Özgür GÖKÇE | 479–484 |
| Is prostate sparing surgery a safe technique for radical cystectomy with orthotopic neobladder? | Cenk Murat YAZICI,Süheyla BOZKURT,Levent TÜRKERİ | 485–489 |
| The rate of incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer | Fatih HIZLI,A. İhsan ARIK,Sinan BAŞAY,Emine BENZER,M. Cemil UYGUR | 490–494 |
| Evaluation of serum levels of immunoglobulins (IgA, IgE, IgG, IgM), complement (C3, C4) and C-reactive protein in bladder cancer: A controlled prospective clinical trial | Süleyman KILIÇ,Mehmet BAYRAKTAR,Nihayet BAYRAKTAR,Hüseyin ERGİN,Ali BEYTUR,Mücahit EĞRİ | 495–502 |
| Evaluation of sexual dysfunction in patients with luts, relationship with testosterous, leptin and and serum lipid levels: Re-evaluation after alpha blocker treatment abstract | Ali RODOPLU,Burak TURNA,Barış ALTAY,Mehmet UMUL,Bülent SEMERCİ | 508–515 |
| Results of 78 intrauterine insemination (IUI) cycles with husband sperm in infertility and factors affecting IUI success: A retrospective study | SÜLEYMAN KILIÇ,Ali BEYTUR,Bülent ALTUNOLUK,Leyla BEYTUR,Fatih OĞUZ,Ruşen ATMACA | 516–523 |
| KTP laser for photoselective vaporization of the prostate in treatment of BPH | Ender ÖZDEN,Ahmet ŞAHİN | 533–538 |
| Frequency of endourological procedures and application of new technologies in Turkey: Results of an questionnaire-based study |